Intraosseous Devices Market Size, Growth and Forecast 2032
Intraosseous Devices Market By Product Type (Manual Intraosseous Devices, Semi-automatic Intraosseous Devices, Battery-powered Intraosseous Devices); By Application (Trauma and Emergency Care, Cardiac Arrest and Resuscitation, Shock and Dehydration Management); By End User (Hospitals, Ambulatory Surgical Centers, Emergency Medical Services (EMS)); By Geography – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
The Intraosseous Devices Market size was valued at USD 448 million in 2024 and is anticipated to reach USD 612.55 million by 2032, growing at a CAGR of 3.98% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Intraosseous Devices Market Size 2024
USD 448 million
Intraosseous Devices Market, CAGR
3.98%
Intraosseous Devices Market Size 2032
USD 612.55 million
Intraosseous Devices Market is led by established medical device manufacturers including Teleflex Incorporated, Becton, Dickinson and Company, Cook Medical, PerSys Medical, Pyng Medical Corp., SAM Medical, Aero Healthcare AU Pty Ltd., and Argon Medical Devices, Inc., all of which focus on product innovation, clinical reliability, and strong hospital and emergency service penetration. These players emphasize battery-powered and semi-automatic systems to enhance speed, safety, and success rates in emergency vascular access. Regionally, North America dominates the Intraosseous Devices Market with a 42.6% market share in 2024, driven by advanced emergency care infrastructure, high trauma incidence, and widespread adoption of intraosseous access in hospital and pre-hospital settings. Europe follows with 27.8% share, supported by standardized emergency protocols and strong clinician training across major healthcare systems.
Intraosseous Devices Market Insights
The Intraosseous Devices Market was valued at USD 448 million in 2024 and is projected to reach USD 612.55 million by 2032, growing at a CAGR of 3.98% during the forecast period.
Market growth is driven by rising emergency cases, increased trauma incidents, and strong adoption of intraosseous access for rapid vascular delivery in hospitals and emergency medical services.
Battery-powered intraosseous devices led the market with a 8% segment share in 2024, supported by faster insertion and higher clinical success, while trauma and emergency care accounted for 49.6% application share.
Market competition is shaped by product innovation, clinician training, and expansion of battery-powered and semi-automatic systems by leading manufacturers to improve procedural efficiency.
Regionally, North America dominated with a 6% share in 2024, followed by Europe at 27.8% and Asia Pacific at 19.4%, driven by advanced emergency infrastructure and expanding trauma care systems.
The Intraosseous Devices Market by product type is led by battery-powered intraosseous devices, which accounted for 56.8% of the market share in 2024, driven by their rapid insertion capability, consistent penetration force, and higher success rates in critical care settings. These devices are widely adopted in emergency departments and pre-hospital care due to reduced procedure time and minimal operator dependency. Semi-automatic intraosseous devices held 27.4% share, supported by cost-effectiveness and controlled deployment, while manual intraosseous devices captured 15.8% share, primarily used in low-resource settings owing to their simple design and lower acquisition cost.
For instance, Teleflex’s EZ-IO system achieved a 96.2% success rate for intraosseous access and infusion in 106 pediatric cases, with a mean device use duration of 60 hours and only 1.9% adverse events.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
By application, trauma and emergency care dominated the Intraosseous Devices Market with a 49.6% market share in 2024, supported by the rising incidence of road accidents, mass-casualty events, and the need for immediate vascular access when intravenous routes fail. Cardiac arrest and resuscitation accounted for 31.2% share, driven by protocol inclusion of intraosseous access in advanced life support guidelines. Shock and dehydration management represented 19.2% share, benefiting from increased use in pediatric and geriatric emergencies where peripheral venous access is challenging and rapid fluid administration is critical.
For instance, PerSys Medical’s Bone Injection Gun (B.I.G.) established IO access in under 60 seconds for adult trauma patients, providing high-flow infusion rates similar to peripheral IVs with a simple position-and-press mechanism.
By End User:
The end-user segment is dominated by hospitals, which held a 61.4% market share in 2024, due to high patient inflow, availability of trained professionals, and integration of intraosseous access into emergency and critical care protocols. Emergency medical services (EMS) accounted for 26.7% share, driven by growing adoption in pre-hospital trauma care and cardiac emergencies requiring rapid intervention. Ambulatory surgical centers represented 11.9% share, supported by their expanding role in urgent care procedures and increasing preparedness for emergency vascular access in outpatient surgical environments.
Key Growth Drivers
Rising Demand for Rapid Vascular Access in Emergency Care
The Intraosseous Devices Market is strongly driven by the growing need for rapid and reliable vascular access in emergency and critical care settings. In trauma cases, cardiac arrest, and severe shock, traditional intravenous access often fails due to collapsed veins or time constraints. Intraosseous devices enable immediate access to the vascular system through bone marrow, ensuring fast drug and fluid delivery. Increasing emergency admissions, road accidents, and cardiac emergencies globally are accelerating adoption across hospitals and pre-hospital settings, making intraosseous access a standard component of advanced life support protocols.
For instance, BD’s system delivered controlled insertions in EMS training for adults and pediatrics, featuring needlestick prevention during high-stress resuscitations. It enabled rapid fluid delivery when IV failed in critical emergencies.
Expansion of Pre-Hospital and Emergency Medical Services
The expanding role of emergency medical services significantly fuels growth in the Intraosseous Devices Market. EMS providers increasingly rely on intraosseous access as a first-line solution during pre-hospital care when intravenous insertion is not feasible. Growing investments in ambulance infrastructure, trauma response systems, and paramedic training across developed and emerging economies are reinforcing demand. Standardization of intraosseous device usage in emergency response guidelines further supports widespread adoption, particularly in time-critical scenarios where rapid intervention directly influences patient survival outcomes.
For instance, Southwestern Ontario EMS agencies reported 83.7% successful prehospital IO access using semi-automatic devices in pediatric patients aged 0-17, with a median insertion time of 4 minutes.
Technological Advancements in Device Design
Continuous technological innovation is a major driver enhancing the growth of the Intraosseous Devices Market. Manufacturers are focusing on battery-powered and semi-automatic systems that improve insertion accuracy, reduce procedure time, and minimize complications. Ergonomic designs, single-use sterile kits, and enhanced safety features are improving clinician confidence and ease of use. These advancements are increasing acceptance across diverse healthcare settings, including emergency rooms, intensive care units, and field operations, while also supporting broader adoption among less-experienced healthcare professionals.
Key Trends & Opportunities
Integration of Intraosseous Access into Clinical Protocols
A prominent trend shaping the Intraosseous Devices Market is the formal integration of intraosseous access into clinical guidelines for emergency and resuscitation care. Advanced cardiac life support and trauma management protocols increasingly recommend intraosseous devices when intravenous access is delayed or unsuccessful. This institutional endorsement is creating long-term opportunities for manufacturers to expand hospital contracts and EMS deployments. Additionally, rising awareness and training initiatives among healthcare professionals are improving procedural familiarity, supporting consistent device utilization across adult and pediatric emergency care pathways.
For instance, Training programs like those using the BD Intraosseous Vascular Access System achieve 93-97% first-pass success rates post short sessions with video and simulation, enabling paramedics and nurses to integrate IO into prehospital resuscitation for both adults and pediatrics when IV access delays occur.
Growth Opportunities in Emerging Healthcare Markets
Emerging economies present significant growth opportunities for the Intraosseous Devices Market due to expanding healthcare infrastructure and improving emergency care capabilities. Governments and private healthcare providers are investing in trauma centers, ambulance services, and emergency preparedness programs. Increasing access to affordable intraosseous devices and localized manufacturing initiatives further support market penetration. As awareness of rapid vascular access solutions improves, demand is expected to rise in both urban and semi-urban regions, creating opportunities for manufacturers to broaden their geographic footprint.
For instance, Teleflex Incorporated collaborated with the Indian Society of Anesthesiologists in 2018 to conduct workshops on intraosseous infusion using the Arrow EZ-IO system for anesthesiologists across India.
Key Challenges
High Device Costs and Budget Constraints
High acquisition costs of advanced intraosseous devices pose a key challenge for market growth, particularly in cost-sensitive healthcare systems. Battery-powered systems and disposable components increase overall treatment expenses, limiting adoption in smaller hospitals and resource-limited settings. Budget constraints often force healthcare providers to prioritize conventional intravenous tools, slowing market penetration. Cost-effectiveness concerns also affect procurement decisions in public healthcare systems, creating pressure on manufacturers to balance innovation with affordability.
Risk of Complications and Limited Skilled Workforce
Despite clinical benefits, the Intraosseous Devices Market faces challenges related to potential complications such as infection, extravasation, and improper placement. Limited availability of adequately trained healthcare professionals in certain regions restricts safe and effective usage. Inconsistent training standards across healthcare facilities can reduce clinician confidence and hinder adoption. Addressing this challenge requires continuous education programs, standardized protocols, and improved device designs that minimize user dependency and procedural risks.
Regional Analysis
North America
North America dominated the Intraosseous Devices Market with a 42.6% market share in 2024, supported by advanced emergency care infrastructure, high adoption of trauma protocols, and widespread availability of trained healthcare professionals. The United States drives regional growth due to strong integration of intraosseous access in advanced cardiac life support and emergency medical services. High emergency admission rates, favorable reimbursement frameworks, and continuous technological adoption further support market leadership. Canada also contributes steadily through expanding pre-hospital care systems and increasing awareness of rapid vascular access solutions across emergency and critical care facilities.
Europe
Europe accounted for a 27.8% market share in 2024, driven by well-established healthcare systems and increasing standardization of emergency response protocols. Countries such as Germany, the United Kingdom, and France are key contributors due to rising trauma cases and strong adoption in hospital emergency departments and ambulance services. Regional growth is supported by government investments in emergency preparedness and growing emphasis on clinician training. The increasing use of battery-powered intraosseous devices across both adult and pediatric care settings continues to strengthen Europe’s position in the global market.
Asia Pacific
Asia Pacific captured a 19.4% market share in 2024, reflecting rapid improvements in healthcare infrastructure and emergency care capabilities. Countries including China, Japan, India, and Australia are witnessing rising demand due to increasing road accidents, urbanization, and expanding emergency medical services. Government initiatives to strengthen trauma care networks and growing awareness of intraosseous access among clinicians are key growth drivers. The region also benefits from a large patient population and rising investments in hospital expansion, positioning Asia Pacific as the fastest-growing regional market.
Latin America
Latin America held a 6.1% market share in 2024, supported by gradual improvements in emergency healthcare access and trauma management systems. Brazil and Mexico lead regional demand due to expanding hospital networks and increasing adoption of standardized emergency protocols. Growth is driven by rising incidence of accidents and efforts to enhance pre-hospital emergency response. However, budget constraints and uneven access to advanced devices limit faster adoption. Ongoing investments in healthcare modernization and training programs are expected to strengthen the regional presence of intraosseous devices.
Middle East & Africa
The Middle East & Africa accounted for a 4.1% market share in 2024, driven by increasing investments in emergency and trauma care infrastructure, particularly in Gulf Cooperation Council countries. Expansion of ambulance services, military medical preparedness, and growing awareness of rapid vascular access solutions support regional growth. South Africa contributes significantly due to its developing trauma care systems. However, limited access to advanced devices and workforce shortages in parts of Africa restrain broader adoption, keeping the region’s market share comparatively lower.
Intraosseous Devices Market Segmentations:
By Product Type
Manual intraosseous devices
Semi-automatic intraosseous devices
Battery-powered intraosseous devices
By Application
Trauma and emergency care
Cardiac arrest and resuscitation
Shock and dehydration management
By End User
Hospitals
Ambulatory surgical centers
Emergency medical services (EMS)
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Competitive Landscape
Competitive landscape of the Intraosseous Devices Market is characterized by the presence of key players such as Teleflex Incorporated, Becton, Dickinson and Company, Cook Medical, PerSys Medical, Pyng Medical Corp., SAM Medical, Aero Healthcare AU Pty Ltd., and Argon Medical Devices, Inc. These companies focus on strengthening their market position through product innovation, portfolio expansion, and strategic partnerships with hospitals and emergency medical services. Battery-powered and semi-automatic device advancements remain central to competition, as manufacturers aim to improve ease of use, insertion success rates, and procedural safety. Leading players emphasize regulatory approvals, clinician training programs, and global distribution expansion to enhance adoption. Competitive intensity is further shaped by pricing strategies and the introduction of single-use sterile kits to meet infection control standards. Emerging players compete by offering cost-effective solutions, particularly targeting developing healthcare markets, while established firms leverage strong brand recognition and clinical validation to maintain leadership.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In May 2024, Teleflex Incorporated launched the Arrow™ EZ-IO™ Intraosseous Access Procedure Tray, a sterile, single-use kit that includes a battery-powered driver and complete set of components for streamlined intraosseous vascular access procedures, enhancing clinician workflow in critical care settings.
In October 2024, Becton, Dickinson and Company (BD) introduced an enhanced BD® IO System designed to provide rapid vascular access for adult and pediatric patients, featuring integrated passive needle tip safety and a rechargeable battery-powered driver to improve safety and performance in emergency care.
Report Coverage
The research report offers an in-depth analysis based on Product Type, Application, End Userand Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
The Intraosseous Devices Market will continue to benefit from increasing reliance on rapid vascular access in emergency and critical care settings.
Adoption of intraosseous access will expand further across pre-hospital emergency medical services due to time-critical intervention requirements.
Technological advancements will focus on improving device safety, insertion accuracy, and ease of use for diverse clinical environments.
Battery-powered and semi-automatic devices will gain stronger preference over manual systems in advanced healthcare facilities.
Growing inclusion of intraosseous access in standardized clinical and resuscitation protocols will support sustained demand.
Emerging economies will witness faster adoption as healthcare infrastructure and trauma care capabilities improve.
Training programs and simulation-based education will enhance clinician proficiency and confidence in device usage.
Manufacturers will increasingly emphasize cost-optimized products to improve penetration in budget-constrained healthcare systems.
Strategic collaborations with hospitals and emergency service providers will strengthen market presence and distribution reach.
Focus on pediatric and geriatric emergency care applications will create new growth opportunities for intraosseous device manufacturers.
Table of Contents (The complete Toc, LoF and LoT are available in the sample report)
Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope
Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology
Executive Summary
Introduction
4.1. Overview
4.2. Key Industry Trends
Global Intraosseous Devices Market
5.1. Market Overview
5.2. Market Performance
5.3. Impact of COVID-19
5.4. Market Forecast
Market Breakup by Region
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Asia-Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Australia
9.2.6. Indonesia
9.2.7. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Others
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Others
9.5. Middle East and Africa
9.5.1. Market Trends
9.5.2. Market Breakup by Country
9.5.3. Market Forecast
Porter’s Five Forces Analysis
12.1. Overview
12.2. Bargaining Power of Buyers
12.3. Bargaining Power of Suppliers
12.4. Degree of Competition
12.5. Threat of New Entrants
12.6. Threat of Substitutes
Price Analysis
Competitive Landscape
14.1. Market Structure
14.2. Key Players
14.3. Profiles of Key Players
14.3.1. Teleflex Incorporated
14.3.2. Becton, Dickinson and Company
14.3.3. Cook Medical
14.3.4. PerSys Medical
14.3.5. Biopsybell S.R.L. (BPB Medica)
14.3.6. Pyng Medical Corp.
14.3.7. Aero Healthcare AU Pty Ltd.
14.3.8. PAVmed Inc.
14.3.9. SAM Medical
14.3.10. Argon Medical Devices, Inc.
Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the current market size for the Intraosseous Devices Market, and what is its projected size in 2032?
The Intraosseous Devices Market was valued at USD 448 million in 2024 and is projected to reach USD 612.55 million by 2032, reflecting steady growth over the forecast period.
At what Compound Annual Growth Rate is the Intraosseous Devices Market projected to grow between 2024 and 2032?
The Intraosseous Devices Market is expected to grow at a Compound Annual Growth Rate of 3.98% between 2024 and 2032.
Which Intraosseous Devices Market segment held the largest share in 2024?
In the Intraosseous Devices Market, battery-powered intraosseous devices held the largest share in 2024 due to faster insertion and higher clinical success rates.
What are the primary factors fueling the growth of the Intraosseous Devices Market?
Growth of the Intraosseous Devices Market is driven by rising emergency cases, expanding emergency medical services, and increasing adoption of rapid vascular access solutions.
Who are the leading companies in the Intraosseous Devices Market?
Key players in the Intraosseous Devices Market include Teleflex Incorporated, Becton, Dickinson and Company, Cook Medical, and SAM Medical.
Which region commanded the largest share of the Intraosseous Devices Market in 2024?
North America commanded the largest share of the Intraosseous Devices Market in 2024, supported by advanced emergency care infrastructure and high adoption rates.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The North America Over-the-Counter (OTC) Drugs Market size was valued at USD 72,391.68 MN in 2021 and reached USD 93,061.46 MN in 2025. It is anticipated to reach USD 155,694.86 MN by 2032, growing at a CAGR of 6.49% during the forecast period.
The North America Specialty Pharmaceuticals Market size was valued at USD 67,838.21 MN in 2021 and reached USD 109,086.83 MN in 2025. It is anticipated to reach USD 260,733.67 MN by 2032, growing at a CAGR of 11.03% during the forecast period.
The Europe Prescription Drugs Market size was valued at USD 294,866.12 MN in 2021 and reached USD 365,960.68 MN in 2025. It is anticipated to reach USD 553,623.53 MN by 2032, growing at a CAGR of 5.13% during the forecast period.
Cell therapy consumables Market was valued at USD 3439 million in 2024 and is anticipated to reach USD 7533.31 million by 2032, growing at a CAGR of 10.3% during the forecast period.
The Africa Orphan Drugs Market size was valued at USD 792.75 MN in 2021 and reached USD 1,258.16 MN in 2025. It is anticipated to reach USD 2,826.51 MN by 2032, growing at a CAGR of 6.30% during the forecast period.
The Africa Biosimilars Market size was valued at USD 126.63 MN in 2021 and reached USD 200.98 MN in 2025. It is anticipated to reach USD 451.50 MN by 2032, growing at a CAGR of 7.80% during the forecast period.
The Europe Dermatology Drugs Market size was valued at USD 8,384.62 MN in 2021 and reached USD 10,909.79 MN in 2025. It is anticipated to reach USD 17,933.36 MN by 2032, growing at a CAGR of 6.18% during the forecast period.
The North America Pain Management Drugs Market size was valued at USD 11,968.20 MN in 2021 and reached USD 14,314.26 MN in 2025. It is anticipated to reach USD 18,345.24 MN by 2032, growing at a CAGR of 2.85% during the forecast period.
The North America Respiratory Drugs Market size was valued at USD 4,603.33 MN in 2021 and reached USD 5,912.29 MN in 2025. It is anticipated to reach USD 8,990.65 MN by 2032, growing at a CAGR of 5.07% during the forecast period.
The North America CNS Drugs Market size was valued at USD 29,971.81 MN in 2021 and reached USD 39,376.62 MN in 2025. It is anticipated to reach USD 64,694.22 MN by 2032, growing at a CAGR of 6.13% during the forecast period.
The Asia Pacific Gastrointestinal Drugs Market size was valued at USD 14,076.07 MN in 2021 and reached USD 18,379.23 MN in 2025. It is anticipated to reach USD 27,675.57 MN by 2032, growing at a CAGR of 4.86% during the forecast period.
The North America Immunology Drugs Market size was valued at USD 23,174.02 MN in 2021 and reached USD 34,194.85 MN in 2025. It is anticipated to reach USD 70,564.69 MN by 2032, growing at a CAGR of 9.11% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
